Moreover, while our study primarily explored the role of SFRP2 in PAH-related fibroblast proliferation and apoptosis resistance, further validation is needed to determine whether PANoptosis plays a definitive role in PAH pathogenesis. The gene discussed is SFRP2; the disease is pulmonary arterial hypertension.